Clinical trialNCT06400342Not, yet, recruitingInterventional

Randomized Evaluation for Failed TAVR

SponsorMedstar Health Research InstituteEnrollment264Prosthesis FailureProsthetic Valve MalfunctionSymptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

REVIVE TAVR is an acronym for the Randomized Evaluation of Valve-In-Valve versus Explantation for failed TAVR. This is a prospective, multicenter, global randomized trial investigating the safety and efficacy of reintervention for transcatheter heart valve (THV) failure by comparing redo-TAVR (TAV-in-TAV) with TAVR surgical explantation (TAVR-explant) in subjects who are suitable for both options in a real-world clinical setting

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Kalyan Chitturi, DO
MedStar Health Research Organization
Study Chair
clinicaltrials.gov ↗
Michael Reardon, MD
MedStar Health Research Organization
Study Chair
clinicaltrials.gov ↗
Ron Waksman, MD
MedStar Health Research Organization
Principal Investigator
clinicaltrials.gov ↗
Thomas MacGillivray, MD
MedStar Health Research Organization
Study Chair
clinicaltrials.gov ↗
Toby Rogers, MD
MedStar Health Research Organization
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Mar 2025
Primary completion: 1 May 2034
Completion: 1 May 2036
Last update posted: 24 Jan 2025
Registered enrollment: 264
Registry id: NCT06400342

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.